ghk-cu-ship-us GHK-CU – Research Peptide GHK-Cu Topical: Evidence, Safety &

Researchers and procurement buyers requiring a larger format may also review GHK-Cu x 10 Vials

Attempting to scavenge a final partial dose from residual volume introduces more error than the peptide is worth

Athletes should note that these compounds fall within categories prohibited by the World Anti-Doping Agency and are not permitted in tested competition.

requires medical knowledge to minimize risk Intranasal Intranasal delivery to target the olfactory bulb and trans-cribriform access to the brain has been explored for some peptides: Theoretical advantage: Direct CNS access, bypassing the blood-brain barrier Reality: Intranasal peptide formulations are complex and Dihexa is not commonly available in this form Evidence: No published data on intranasal Dihexa efficacy or safety Oral Bioavailability: Approximately 38% The most commonly cited bioavailability figure for oral Dihexa is approximately 38%

Activation of these receptors can sometimes cause a slight increase in heart rate